EP-1337 IMRT/VMAT vs. 3DCRT: the pathological and the clinical outcomes in LANSCLC treated with trimodality. (April 2019) - Appel, S.; Lawrence, Y.R.; Symon, Z.; Haisraely, O.; Perlman, M.; Ofek, E.; Alezra, D.; Katzman, T.; Honig, N.; Ben-ayun, M.; Alezra, T. Rabin; Dubinsky, S.; et al.